Adenosine 5′-triphosphate (ATP) supplements are not orally bioavailable: a randomized, placebo-controlled cross-over trial in healthy humans

Ilja CW Arts1 Department of EpidemiologyMaastricht UniversityP.O. Box 6166200MaastrichtMDThe NetherlandsCorrespondence[email protected]

Erik JCM Coolen1 Department of EpidemiologyMaastricht UniversityP.O. Box 6166200MaastrichtMDThe Netherlands;2 Department of ToxicologyMaastricht UniversityP.O. Box 6166200MaastrichtMDThe Netherlands

Martijn JL Bours1 Department of EpidemiologyMaastricht UniversityP.O. Box 6166200MaastrichtMDThe Netherlands

Nathalie Huyghebaert3 Laboratory of Pharmaceutical Technology, Faculty of Pharmaceutical SciencesGhent UniversityHarelbekestraat 72B-9000GhentBelgium

Martien A Cohen Stuart4 Department of Agrotechnology and Food Sciences, Laboratory of Physical Chemistry and Colloid ScienceWageningen UniversityP.O. Box 80386700WageningenEKThe Netherlands

Aalt Bast2 Department of ToxicologyMaastricht UniversityP.O. Box 6166200MaastrichtMDThe Netherlands

Pieter C Dagnelie1 Department of EpidemiologyMaastricht UniversityP.O. Box 6166200MaastrichtMDThe Netherlands

show all

Adenosine 5′-triphosphate (ATP) supplements are not orally bioavailable: a randomized, placebo-controlled cross-over trial in healthy humans

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Adenosine 5′-triphosphate (ATP) supplements are not orally bioavailable: a randomized, placebo-controlled cross-over trial in healthy humans

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date